August 2018

$19.9M Contract Renewal for MRIGlobal’s Chemopreventive Agent Repository Program

MRIGlobal has been awarded a 5-year, $19.9 million contract from the National Institutes of Health (NIH)/National Cancer Institute (NCI)/Division of Cancer Prevention to continue to operate the Centralized Chemopreventive Agent Repository and Drug Chemistry Support program. Learn More >

 

Population Health Expert, Dr. David Nash, Will Headline BioNexus KC’s Annual Dinner

On September 20 BioNexus KC’s Annual Dinner will dive deep into population health at the Arvest Bank Theatre at the Midland. Learn More > 

 

Children’s Mercy CEO Exits Early; COO Takes the Reins

Children’s Mercy CEO Randall O’Donnell will step down early, leaving COO Jo Stueve leading the hospital. Learn More > 

 

 

Click here for a full list of stories.

Share:

Interested in Getting more involved with BioNexus KC and our events?